We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ovoca Gold | LSE:OVG | London | Ordinary Share | IE00B4XVDC01 | EUR0.125 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.25 | 9.50 | 11.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
05/7/2018 00:05 | Why is the chart flat-lining this afternoon? | fenners66 | |
04/7/2018 13:30 | Hazel,the master of misinformation, posting after a long absence even though she does not hold. | fiachra | |
04/7/2018 09:27 | https://youtu.be/8hD | bob1995 | |
04/7/2018 09:24 | https://www.youtube. | bob1995 | |
04/7/2018 09:17 | I don’t regret selling, i sold based on my own concerns following several interactions with the company. If I had still held I would have sold this AM having read the RNS, irrespective of the rise. I am unconvinced and skeptical about today’s announcement. | oli12 | |
04/7/2018 08:53 | Well I have read the whole RNS and there is Nothing in there that says this is an arms length transaction....... | fenners66 | |
04/7/2018 08:52 | The Company operates a share option plan which was adopted on 20 July 2009 and which gives employees, directors and consultants of companies within the Group the opportunity to acquire shares in the Company. The Remuneration Committee will consider a timetable for proposed awards following Admission WHAT ?! They have been doing NOTHING for the last 9 years !!! | fenners66 | |
04/7/2018 08:51 | " Remuneration committee The remuneration committee will be chaired with effect from Admission by Mikhail Mogutov with Leonid Skoptsov being the other member of the committee. It is expected to meet not less than two times a year. Directors may attend meetings at the committee's invitation. The remuneration committee has responsibility for determining, within agreed terms of reference, the Enlarged Group's policy on the remuneration of senior executives and specific remuneration packages for executive Directors, including pension rights and compensation payments. It is also responsible for selecting individuals to whom to make grants of awards under the Share Option Scheme. " haha the enlarged group will have enlarged directors' remuneration no doubt and we know they give out cash just for attending the meetings .... to work out how much cash they will be giving out..... | fenners66 | |
04/7/2018 08:47 | How come after all these years they now want to tell us about the Directors' backgrounds ? | fenners66 | |
04/7/2018 08:43 | OIL12 I told you you shouldn't let bitter stale-bulls frighten you off. (NOT A CURRENT HOLDER) | hazl | |
04/7/2018 08:43 | They go on to talk about other treatments that failed and other deals that are now commercial failure and subject to litigation...which is to try and say there is no competition However does it also point the way to similar outcomes here ? | fenners66 | |
04/7/2018 08:40 | "Since 31 December 2017, Ovoca has traded in line with management expectations. Mining and exploration operations remain suspended at the Company's licence areas in Russia" "During the remainder of 2018, the Company will continue to rigorously pursue all available legal options to recover amounts due to it pursuant to the loans previously extended to Taymura LLC, including the pursuit of the personal guarantees which were used to secure the loan. However, there can be no guarantee that the entire loan amount will be recovered by Ovoca. " Tell us something we did not know years ago | fenners66 | |
04/7/2018 08:39 | A CERTAIN MULTI BAGGER GUYS, WELLDONE | alia | |
04/7/2018 08:36 | Worth billions possibly.. Wow | letmepass | |
04/7/2018 08:34 | "but there can be no guarantee that a patent will be granted on foot of such applications" | fenners66 | |
04/7/2018 08:34 | The next viagra | letmepass | |
04/7/2018 08:29 | Please keep buying. My sell order is being filled as we speak. | jeevsje | |
04/7/2018 08:16 | "initiate a first-in-human clinical study in early 2015." I'm sure it was fnar fnar.......... | fenners66 | |
04/7/2018 08:09 | You called this spot on fenners. | oli12 | |
04/7/2018 08:05 | Not got far enough into the announcement to find out whether it is a linked or 3rd party transaction. | fenners66 | |
04/7/2018 08:03 | "It now intends to complete the Russian Phase III clinical trial for Libicore in Q3 2019 and expects to have the results available by Q2 2019," Ha Ha the Soviet election results are strong with this one....... Results available Q2 2019 but the tests will not be done until Q3 2019...... haha | fenners66 |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions